Fidelity Investments’s Counterpath Corp CPAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-284,450
Closed -$811K 2805
2018
Q1
$811K Hold
284,450
﹤0.01% 2470
2017
Q4
$907K Hold
284,450
﹤0.01% 2457
2017
Q3
$743K Hold
284,450
﹤0.01% 2442
2017
Q2
$537K Hold
284,450
﹤0.01% 2498
2017
Q1
$642K Hold
284,450
﹤0.01% 2506
2016
Q4
$691K Hold
284,450
﹤0.01% 2519
2016
Q3
$594K Hold
284,450
﹤0.01% 2526
2016
Q2
$605K Hold
284,450
﹤0.01% 2526
2016
Q1
$764K Sell
284,450
-1,800
-0.6% -$4.02K ﹤0.01% 2511
2015
Q4
$827K Sell
286,250
-1,500
-0.5% -$5.06K ﹤0.01% 2546
2015
Q3
$927K Hold
287,750
﹤0.01% 2529
2015
Q2
$1.36M Hold
287,750
﹤0.01% 2504
2015
Q1
$1.68M Hold
287,750
﹤0.01% 2439
2014
Q4
$1.64M Hold
287,750
﹤0.01% 2460
2014
Q3
$2.75M Hold
287,750
﹤0.01% 2358
2014
Q2
$3.1M Hold
287,750
﹤0.01% 2334
2014
Q1
$4.29M Hold
287,750
﹤0.01% 2238
2013
Q4
$3.12M Hold
287,750
﹤0.01% 2270
2013
Q3
$4.02M Hold
287,750
﹤0.01% 2212
2013
Q2
$4.51M Buy
+287,750
New +$5.22M ﹤0.01% 2164

Other funds holding CPAH

Fidelity Investments's CPAH Position: Q2 2018 in Review

Fidelity Investments sold out of Counterpath Corp (CPAH) in Q2 2018, closing a stake of 284,450 shares — an estimated $811K sold.

Fidelity Investments first reported a position in CPAH in Q2 2013 and held it in 20 quarters. The position peaked at $4.51M in Q2 2013. 6 funds tracked by Wall St. Rank hold CPAH as of Q2 2018.

  • Fidelity Investments reported no remaining Counterpath Corp position as of Q2 2018 after selling out during the quarter.
  • Fidelity Investments sold 284,450 Counterpath Corp shares in Q2 2018, an estimated $811K.
  • Fidelity Investments first reported a position in Counterpath Corp in Q2 2013 and held it in 20 quarters.
  • Fidelity Investments's Counterpath Corp position peaked at $4.51M in Q2 2013.
  • 6 funds tracked by Wall St. Rank held Counterpath Corp as of Q2 2018.

Based on Fidelity Investments's 13F filing for Q2 2018, filed 10 Aug 2018.